Pharmacokinetic considerations in the choice of beta-blockers and their dosage.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006207:Half-Life; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D011433:Propranolol / Q000097:blood / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011433:Propranolol